medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2010, Número 2

<< Anterior Siguiente >>

Rev Biomed 2010; 21 (2)


Infecciones en humanos por bacterias anaerobias del género Bacteroides: actualización en aspectos taxonómicos, bioquímicos, inmunológicos, patogénicos y clínicos

Quesada-Gómez C

Idioma: Español
Referencias bibliográficas: 55
Paginas: 89-96
Archivo PDF: 78.03 Kb.


RESUMEN

Las bacterias anaerobias más frecuentemente aisladas a partir de muestras clínicas se clasifican en el género Bacteroides. En esta revisión, se pretende realizar una actualización breve sobre los cuadros clínicos asociados con cepas de este género, la epidemiología de sus infecciones, los principales factores de virulencia y mecanismos patogénicos descritos para este grupo bacteriano, generalidades acerca de su aislamiento, identificación, caracterización y taxonomía y una pequeña descripción sobre el manejo terapéutico. Además, se aportan aspectos novedosos sobre la inmunología del hospedero y la interacción de estas bacterias con el humano. Con esta contribución, se espera brindar fundamentos teóricos para que los profesionales en salud e investigadores latinoamericanos consideren a las bacterias del género Bacteroides en sus diagnósticos presuntivos; asimismo, incentivar el desarrollo de la bacteriología anaerobia clínica en América Latina.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rodríguez-Cavallini E, Quesada-Gómez C. Bacteriología anaerobia: principios clínicos y diagnóstico de laboratorio. 1a ed. San José, Costa Rica: Lara Segura & Asociados; 2008. p. 132.

  2. Finegold S. Anaerobic bacteria. En: Principles and Practice of Infectious Diseases. 5a ed. EUA: Churchill Livingstone; 2000. p. 2519 – 37.

  3. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold S. Wadsworth – KTL: Anaerobic Bacteriology Manual. 6a ed. Los Angeles, EUA: Star Company; 2002. p. 287.

  4. Brook I. Anaerobic infections: Diagnosis and management. 1a ed. EUA: Informa Healthcare Inc.; 2008. p. 417.

  5. Awadel-Kariem FM, Patel P, Kapoor J, Brazier J, Goldstein EJ. First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intraabdominal infection. Anaerobe 2010; 16: 223–5.

  6. Field TR, Sibley CD, Parkins MD, Rabin HR, Surette MG. The genus Prevotella in cystic fibrosis airways. Anaerobe 2010; doi: 10.1016/j. anaerobe.2010.04.002.

  7. Jusko M, Potempa J, Potempa 7. M, Popadiak K, Riesbeck K, Eick S, Blom AN. Proteases of periodontal pathogens Porphyromonas gingivalis, Tannerella forsythia and Prevotella intermedia target all pathways of the complement system. Mol Immunol 2010; 47:2240.

  8. Roças IN, Siqueira JF. Distribution of Porphyromonas gingivalis genotypes in primary endodontic infections. Oral Surgery, Oral Medicina, Oral Pathology, Oral Radiology and Endodontology 2010; 109:474–8.

  9. Miao L, Liu Y, Li Q, Wang Z, Li H, Zhang G. Screening and sequence analysis of the hemolysin gene of Fusobacterium necrophorum. Anaerobe 2010; doi:10.1016/j.anaerobe.2010.04.005.

  10. Schumacher UK., Maennel M., Werner H. Adherence of Bacteroides species and Bilophila wadsworthia to phospholipids and glycolipids. Anaerobe 2000; 6:61–3.

  11. Golstein EJ., Citron DM. Activity of novel carbapenem, doripenem against anaerobic pathogens. Diag Microbiol Infect Dis 2009; 63:447–54.

  12. Minces LR, Shields RK, Sheridan K, Ho KS, Silveira FP. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature. Anaerobe 2010; doi:10.10116/j.anaerobe.2010.03.011.

  13. Citron DM, Kwok YY, Appleman MD. In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci. Anaerobe 2005; 11:93–5.

  14. Ota-Tsuzuki C, Mayer MP. Collagenase production and hemolytic activity related to 16S rRNA variability among Parvimonas micra oral isolates. Anaerobe 2010; 16:38–42.

  15. Duerden BI, Brazier J. Tetanus and other clostridial and anaerobic infections. Medicine 2005; 33:103–5.

  16. Kaplan I, Anavi K, Anavi Y, Shlomo C. The clinical spectruym of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis. Oral Surgery, Oral Medicina, Oral Pathology, Oral Radiology and Endodontology 2009; 108:738–46.

  17. Söderquist B, Holmberg A, Unemo M. Propionibacterium acnes as an etiological agent of arthroplastic and osteosynthetic infections – two cases with specific clinical presentation including formation of draining fistulae. Anaerobe 2010; 16:304–6.

  18. Sahuquillo-Arce J, Ramirez-Galleymore P, Garcia J, Marti V, Arizo D. Mobiluncus curtisii bacteremia. Anaerobe 2008; 14: 123-4.

  19. Garre M, Henaff CL, Chailloux J, Bensousan T, Garo B, Boles JM. Fulminant Eubacterium plautii infection following dog bite in asplenic man. The Lancet 1991; 338:384-5.

  20. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediat 2010; 156:679-81.

  21. Lau S, Woo P, Woo G, Fung A, Wong M, Chan K, Tam D, Yuen K. Eggerthella hongkongensis sp. nov. And Eggetherlla sinensis sp. nov., two novel Eggerthella species, account for half the cases of Eggerthella bacteremia. Diag Microbiol Infect Dis 2004; 49:255-63.

  22. Kageyama A, Sakamoto M, Benno Y. Rapid identification and quantification of Collinsella aerofaciens using PCR. FEMS Microbiol Lett 2000; 183:43-7.

  23. Jumas-Bilak E, Jean-Pierre H, Carlier J, Teyssier C, Bernard K, Gay B, et al. Dialister micraerophilus sp. nov. and Dialister propionicifaciens sp nov. isolated from human clinical samples. Int J Syst Evoul Micriobiol 2005; 55:2471-8.

  24. Finegold S. Changes in taxonomy, anaerobes associated with humans, 2001 – 2004. Anaerobe 2004; 10:309-12.

  25. Boo TW, Cryan B, O’Donell A, Fahy G. Prosthetic valve endocarditis caused by Veillonella párvula. J Infection 2005; 50:81-3.

  26. Aldridge MA, Ashcraft D, Cambre K, Pierson CL, Jenkins SG. Multicentric survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group: Distribution of species, beta-lactamase production and antimicrobial susceptibility patterns. Antimicrob Agents Chemother 2003; 47:148-53.

  27. Finegold S, Baron E, Wexler H. A clinical guide to anaerobic infections. 1a ed. EUA: Star Publishing Company; 1992. p. 3-91.

  28. Paster B, Dewhirst F, Olsen I, Fraser G. Phylogeny of Bacteroides, Prevotella, and Porphyromonas spp. and related bacteria. J Bacteriology 1994;176 725-32.

  29. Falagas ME, Siakavellas E. Bacteroides, Prevotella and Porphyromonas species: a review of antibiotic resistance and therapeutic options. Int J Antimicrob Agents 2000; 15:1-9.

  30. Wexler HM. Bacteroides: the good, the bad and the nitty- gritty. Clinical Microbiol Rev 2007; 20:593-621.

  31. Boente RF, Ferreira LQ, Falcao LS, Miranda KR, Guimaraes PLS, Santos-Filho J, et al. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Anaerobe 2010; 16:190-4.

  32. Xu J, Bjursell MK, Himrod J, Deng D. Carmichael LK, Chiang HC, et al. A genomic view of the human- Bacteroides thetaiotaomicron symbiosis. Science 2003; 299:2074-6.

  33. Ferreira EO, Falcao LS, Vallim DC, Santos FJ, Andrade JRC, Andrade AFB, et al. Bacteroides fragilis adherence to CACO-2 cells. Anaerobe 2002; 8:307-14.

  34. Zocco MA, Ainora ME, Gasbarrini G, Gasbarrini A. Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction. Digestive and Liver disease 2007; 39:707-12.

  35. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of comensal hostmicrobial relationships in the intestine. Science 2001; 291:881-4.

  36. Bevins C. Events at the Host-Microbial Interface of the Gastrointestinal Tract V. Paneth cell a-defensins in intestinal host defense. Am J Physiol Gastrointest Liver Physiol 2005; 289:173-6.

  37. Cash HL, Whitham CV, Berhrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Sience 2006; 313:1126-30.

  38. Ko KS, Kuwahara T, Lee K, Kook Y. Population structure and distribution of virulence-related genes of Bacteroides fragilis isolates from Korea and Japan. Diag Microbiol Infect Dis 2009; 64:340-3.

  39. Lorber B. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli). En: Principles and Practice of Infectious Diseases, 5a ed. USA: Churchil Livingstone; 2000. p. 2519-37.

  40. Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza R, Wexler H. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epitelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microbial Pathogenesis 2007; 43:78-87.

  41. Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, Kasper DL. Immnunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. Infect Immunity 2001; 69:2339-44.

  42. Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immunity 2001; 69:4342-50.

  43. Robertson KP, Smith CJ, Gouch AM, Rocha ER. Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HLYA and HLYB. Infect Inmmunity 2006; 74:2304-16.

  44. Foulon I, Pierard D, Muydermans G, Vandoorslaer K, Soetens O, Rossel P, et al. Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples. J Clinical Microbiol 2003; 41:4428-30.

  45. Wu S, Shin J, Zhang G, Cohen M, Franco A, Sears CL. The Bacteroides fragilis toxin binds to a specific intestinal epitelial cell receptor. Infect Immunity 2006; 74:5382-90.

  46. Quesada-Gómez C, Gamboa-Coronado MM, Rodríguez-Cavallini E. Bacterias anaerobias como agentes etiológicos de infecciones intraadominales en un hospital de Costa Rica. Rev Pan Infect 2008; 10:13-7.

  47. Claros MC, Claros ZC, Hecht DW, Citron DM, Goldstein EJ, Silva J, et al. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Anaerobe 2006; 12:17-22.

  48. Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK. Analysis of microbial etiology and mortality in patients with brain abscess. J Infection 2006; 53:221-7.

  49. Cáceres M, Zhang G, Weintraub A, Nord CE. Prevalence and antimicrobial susceptibility of enterotoxigenic Bacteroides fragilis in children with diarrhoea in Nicaragua. Anaerobe 2000; 6:143-8.

  50. Pituch H, Obuch-Woszczaty P, Luczak M, Meisel- Miko F. Clostridium difficile and enterotoxigenic Bacteroides fragilis strains isolated from patients with antibiotic associated diarrhoea. Anaerobe 2003; 9:161-3.

  51. Lucke K, Miehlke S, Jacobs E, Schuppler M. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 2006; 55:617-24.

  52. Wu S, Powell J, Mathioudakis N, Kane S, Fernandez E, Sears CL. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin- 8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kB pathway. Infect Immunity 2004; 72:5832-9.

  53. Aldridge K, O’Brien M, In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation ates significantly affects overall susceptibility data. J Clin Microbiol 2002; 40:4349-52.

  54. Wybo I, Pierard D, Verschraegen I, Reynders M, Vandoorslaer K, Claey G, et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. JAC 2007; 59:132-9.

  55. Liu C, Huang Y, Liao C, Yen L, Lin H, Hsueh P. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agent Chemother 2008; 52:3161-8.




2020     |     www.medigraphic.com